England to ban single-use e-cigarettes from June 2025

Oct.24.2024
England to ban single-use e-cigarettes from June 2025
The UK government has announced that England will ban the sale of single-use e-cigarettes from 1 June 2025. On the 22nd of this month, the Welsh Government also issued a statement on its official website confirming a ban on the use of disposable e-cigarettes from June 2025. Currently, two of the four UK regions have issued official statements on the matter.

The UK government announced on its official website on 24th October that England will ban the sale of single-use e-cigarettes from 1 June 2025.

 

Minister for the Circular Economy Mary Creagh confirmed today (24 October) that a new bill has been introduced to Parliament to ban the sale of single-use e-cigarettes from 1 June 2025.

 

The UK government has introduced legislation to ban the sale of remaining stocks by businesses by 1 June 2025, subject to parliamentary approval. Businesses will need to prepare for the ban to take effect. The UK Cabinet Office and local authorities are working closely together to set a consistent date.

 

Between 2012 and 2023, the use of e-cigarettes in England is expected to increase by over 400%, with 9.1% of the UK population currently buying and using these products.

 

Minister for the Circular Economy Mary Creagh said: "Single-use e-cigarettes are extremely wasteful and have caused concern in our towns and cities."

 

"That's why we need to ban single-use e-cigarettes to end the culture of waste in this country," she said. "This is the first step towards a circular economy, where we will extend the use of resources, reduce waste, accelerate progress towards net zero emissions and create thousands of job opportunities across the country."

 

Minister for Public Health and Prevention Andrew Gwynne added: "It is worrying that a quarter of 11-15 year olds used e-cigarettes last year, with disposable e-cigarettes being the choice of most children. Banning disposable e-cigarettes will not only help protect the environment, it will also reduce the appeal of e-cigarettes to children and prevent vulnerable young people from being influenced. The Government will also implement the Tobacco and Electronic Cigarettes Act, the most important public health measure for generations, to protect young people from the effects of nicotine and pave the way for a smoke-free Britain."

 

Green Alliance's Head of Resources, Libby Peake, said: "single-use e-cigarettes are the last thing our children and the planet need, and the unchecked growth of the market for them has gone on for far too long. Each one is a waste of vital resources needed for more sustainable economic development, such as the lithium used in electric vehicle batteries. When littered, the nicotine, plastics and batteries they contain are extremely harmful. Even if thrown away, their batteries can catch fire. Government bans on these harmful devices are a welcome step towards reducing waste in the economy."

 

"The emergence of single-use e-cigarettes, possibly the first mainstream disposable electronic device, is polluting our streets and reflects the continued evolution of the tobacco industry. The UK government's plan to ban these disposable products by 2025 is a popular and important step. The ban not only aims to reduce the number of discarded e-cigarettes, but also challenges the wider trend of disposable technology, which is contributing to a worrying increase in electronic waste, accompanied by fire hazards and the use of scarce materials. From a health perspective, I also welcome this ban and believe it is essential in breaking the control of e-cigarettes over young people and challenging the throwaway culture that threatens to choke our planet," said climate campaigner and environmental scientist, Less Waste Laura.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | PMI Launches TEREA Black Mint Pearl in Japan, Adding First Capsule Variant to Black Range With Nationwide Rollout From October 19
Product | PMI Launches TEREA Black Mint Pearl in Japan, Adding First Capsule Variant to Black Range With Nationwide Rollout From October 19
Philip Morris Japan (PMJ) launched TEREA Black Mint Pearl on October 15, 2026, introducing the first capsule-equipped heated tobacco stick in the TEREA Black range for IQOS ILUMA devices. The product combines a strong menthol profile with a crushable mint capsule and is priced at ¥640 per 20-stick pack, including tax. Sales began at four IQOS stores and selected retail partners on October 15, with distribution expanding to convenience stores and other tobacco retailers nationwide from October 19. The launch brings Japan's TEREA portfolio to 28 variants, including 21 menthol-related products, or 75% of the range.
product
Oct.16 by 2Firsts Perspectives
EU Tobacco Tax Reform Targets November Push as Sweden Holds Nicotine-Pouch Minimum at €20 per Kilogram
EU Tobacco Tax Reform Targets November Push as Sweden Holds Nicotine-Pouch Minimum at €20 per Kilogram
The Irish presidency of the Council of the European Union is using bilateral talks to push the bloc’s Tobacco Taxation Directive toward a political agreement in November. According to Law360, citing an EU official, Sweden is unwilling to accept a minimum excise threshold above €20 per kilogram for nicotine pouches. Council negotiations have already lowered the European Commission’s original proposal, but a May 2026 presidency compromise still set the minimum at 10% of the tax-inclusive retail price or €30 per kilogram in 2028-29, with higher levels later.
Market
Sep.17 by 2Firsts Perspectives
Product | PMI Launches ZYN Melts in UK, Extending ZYN Beyond Nicotine Pouches Into Dissolvable Tablets
Product | PMI Launches ZYN Melts in UK, Extending ZYN Beyond Nicotine Pouches Into Dissolvable Tablets
Philip Morris International (PMI) has launched ZYN Melts in the UK, introducing a fully dissolvable oral nicotine tablet format alongside the brand's existing nicotine pouches. The range includes Cool Mint and Peppermint, each offered at 1mg and 2mg of nicotine per tablet, creating four SKUs. Each can contains 20 tablets and is priced at £6.50 in the UK. Unlike ZYN nicotine pouches, Melts are placed between the upper lip and gum and dissolve completely during use.
News
Sep.29 by 2Firsts Perspectives
2Firsts Hosts China Market Forum at InterTabac as Global Industry Attention to China’s Tobacco Sector Deepens
2Firsts Hosts China Market Forum at InterTabac as Global Industry Attention to China’s Tobacco Sector Deepens
On September 16, 2Firsts hosted a China-focused industry forum during InterTabac in Dortmund, bringing together more than 30 participants from North America, Europe, India, South Korea and other markets. The session covered traditional tobacco, next-generation products, exports, technology, regulation and supply chains, while examining how China’s tobacco sector operates, where its transformation may be heading, and why its growing role matters increasingly to companies across the global tobacco and nicotine industry.
Sep.21
Product | FOGER Introduces Switch Pro 30K Nixodine Pod in U.S. Retail, Bringing 6-MN Related Formulation to High-Capacity Pod Platform
Product | FOGER Introduces Switch Pro 30K Nixodine Pod in U.S. Retail, Bringing 6-MN Related Formulation to High-Capacity Pod Platform
FOGER has introduced the Switch Pro 30K Nixodine Pod in U.S. retail channels, bringing a 6-methylnicotine (6-MN)-related formulation into its reusable Switch Pro 30K pod ecosystem. The product retains the existing reusable dock and magnetic replacement pod architecture, featuring a 19ml prefilled pod, dual-mesh heating and Normal/Boost modes. The Nixodine version is labeled nicotine-free in terms of conventional nicotine but uses a 5% Nixodine-related formulation. The product has appeared in U.S. retail and wholesale channels, with some listings indicating Kentucky-only availability.
Aug.28
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23